World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
22663
World Ranking
2042
National Ranking
999

David H. O’Connor publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David H. O’Connor sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 339 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David H. O’Connor D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David H. O’Connor sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David H. O'Connor is affiliated with the University of Wisconsin-Madison in the United States. Their research primarily lies within the field of Medicine, with a strong focus on Infectious Diseases. Subfields of study engaged by O'Connor include Epidemiology, Molecular Biology, Immunology, and Public Health, Environmental and Occupational Health.

The scientist's work covers several main topics, among which SARS-CoV-2 and COVID-19 research is prominent. Other key topics include SARS-CoV-2 detection and testing, mosquito-borne diseases and control, COVID-19 clinical research studies, virology and viral diseases, viral infections and vectors, and biosensors and analytical detection.

O'Connor has contributed to numerous publications, with frequent venues including bioRxiv (Cold Spring Harbor Laboratory), PLoS Pathogens, Emerging Infectious Diseases, PLoS ONE, and The Journal of Immunology. Their publication record reveals a sustained engagement with high-impact and specialized outlets in infectious disease research.

Recent notable papers authored or co-authored by O'Connor include:

  • "Sequence diversity analyses of an improved rhesus macaque genome enhance its biomedical utility" (2020, Science)
  • "Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models" (2020, Nature Reviews. Immunology)
  • "Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck" (2021, PLoS Pathogens)
  • "Shedding of Infectious SARS-CoV-2 Despite Vaccination" (2021, bioRxiv [Cold Spring Harbor Laboratory])
  • "Persistent SARS-CoV-2 infection: significance and implications" (2024, The Lancet Infectious Diseases)

Frequent collaborators in O'Connor's research include Thomas C. Friedrich, Andrea M. Weiler, Christina M. Newman, Katarina M. Braun, and Dawn M. Dudley. This network of co-authors demonstrates cooperation in both experimental and epidemiological studies related to infectious diseases and viral pathogens.

Best Publications

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components

    Keith Pardee;Alexander A. Green;Melissa K. Takahashi;Dana Braff;Dana Braff;Dana Braff

  • Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.

    Todd M. Allen;David H. O'Connor;Peicheng Jing;John L. Dzuris

  • Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

    David T. Evans;David T. Evans;David H. O'Connor;Peicheng Jing;John L. Dzuris

  • Reversion of CTL escape-variant immunodeficiency viruses in vivo.

    Thomas C Friedrich;Elizabeth J Dodds;Levi J Yant;Lara Vojnov

  • Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.

    David H. O'Connor;Todd M. Allen;Thorsten U. Vogel;Peicheng Jing

  • A rhesus macaque model of Asian-lineage Zika virus infection

    Dawn M Dudley;Matthew T Aliota;Emma L Mohr;Andrea M Weiler

  • HIV-1 superinfection despite broad CD8 + T-cell responses containing replication of the primary virus

    Marcus Altfeld;Todd M. Allen;Xu G. Yu;Mary N. Johnston

  • Biological and structural characterization of a host-adapting amino acid in influenza virus.

    Shinya Yamada;Masato Hatta;Bart L. Staker;Shinji Watanabe

  • Reorganization and expansion of the nidoviral family Arteriviridae

    Jens H. Kuhn;Michael Lauck;Adam L. Bailey;Alexey M. Shchetinin

  • The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

    Levi J. Yant;Thomas C. Friedrich;Randall C. Johnson;Gemma E. May

  • Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

    Danilo R. Casimiro;Fubao Wang;William A. Schleif;Xiaoping Liang

  • Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models

    Rodrigo Delvecchio;Luiza M. Higa;Paula Pezzuto;Ana Luiza Valadão

  • Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239

    Nancy A. Wilson;Jason Reed;Gnankang S. Napoe;Shari Piaskowski

  • Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.

    Tetsuro Matano;Masahiro Kobayashi;Hiroko Igarashi;Akiko Takeda;Akiko Takeda

  • Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses.

    David H. O'Connor;Bianca R. Mothe;Jason T. Weinfurter;Sarah Fuenger

  • Mesenchymal Stem Cells Enhance Allogeneic Islet Engraftment in Nonhuman Primates

    Dora M. Berman;Melissa A. Willman;Dongmei Han;Gary Kleiner

  • Highly efficient maternal-fetal Zika virus transmission in pregnant rhesus macaques

    Sydney M Nguyen;Kathleen M Antony;Dawn M Dudley;Sarah Kohn

  • CD8+ Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing

    Todd M. Allen;Bianca R. Mothé;John Sidney;Peicheng Jing

  • Major histocompatibility complex genotyping with massively parallel pyrosequencing.

    Roger W Wiseman;Julie A Karl;Benjamin N Bimber;Claire E O'Leary

  • A rhesus macaque model of Asia lineage Zika virus infection

    Dawn M. Dudley;Matthew T. Aliota;Emma L. Mohr;Andrea M. Weiler

Frequent Co-Authors

Thomas C. Friedrich
Thomas C. Friedrich University of Wisconsin–Madison
Roger W. Wiseman
Roger W. Wiseman University of Wisconsin–Madison
David I. Watkins
David I. Watkins George Washington University
Tony L. Goldberg
Tony L. Goldberg University of Wisconsin–Madison
Austin L. Hughes
Austin L. Hughes University of South Carolina
Jens H. Kuhn
Jens H. Kuhn National Institutes of Health
Colin A. Chapman
Colin A. Chapman Vancouver Island University
David Baker
David Baker University of Washington
Todd M. Allen
Todd M. Allen Harvard University
Ronald E. Bontrop
Ronald E. Bontrop Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing online nursing degrees can open diverse career opportunities in healthcare. Many students explore specialized paths like psychiatric nursing, where programs such as the top online pmhnp programs offer strong clinical placement rates, ensuring practical experience alongside flexible learning.

Cost is often a significant consideration for students, and looking into the cheapest pmhnp programs online can help aspiring nurse practitioners minimize financial burdens while still obtaining quality education.

For graduates holding a Doctor of Nursing Practice degree, understanding the financial prospects is vital. Data on the highest paid dnp specialties reveals that roles closely aligned with acute and specialized care often command premium salaries.

Additionally, for Family Nurse Practitioners wishing to broaden their skill set, online options like the fnp to acnp bridge program online provide a convenient route to transition into acute care settings, expanding career potential within immunology-related fields.

Best Scientists Citing David H. O’Connor

Trending Scientists

Recently Published Articles